Back to results
US 11,564,942 B2Granted
Methods for generating universal and custom MHC/HLA-compatible hematopoietic progenitor cells
AssigneesThe General Hospital Corporation, President and Fellows of Harvard College
InventorsMichael K. Mansour, David B. Sykes, David T. Scadden
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for generating universal MHC/HLA-compatible hematopoietic progenitor cells and methods for generating custom patient-specific MHC/HLA-compatible hematopoietic progenitor cells. Compositions comprising the universal and custom hematopoietic progenitor cells and therapeutic applications thereof are also disclosed.
Claims3
A method of treating a pathogen infection in a subject in need thereof, said method comprising:
- a) generating custom MHC/HLA-compatible hematopoietic progenitor cells for the subject, said generating comprising the steps of:
- i) a contacting step, wherein the contacting step consists of contacting isolated MHC/HLA-compatible progenitor cells with a fusion protein consisting of a N-terminal cell-penetration peptide and a C-terminal a mixed-lineage leukemia (MLL) oncoprotein, the fusion protein having the sequence of SEQ ID NO:
- 1;
- wherein said isolated progenitor cells are:
- progenitor cells that give rise to subsets of mature blood cells;
- and isolated from bone marrow, peripheral blood, placenta, or umbilical cord of a donor subject;
- and
- ii) a culturing step, wherein the culturing step comprises the progenitor cells of step i) with a combination of multilineage cytokines comprising stem-cell factor (SCF), Flt3 ligand, IL-3, TPO and IL-6, whereupon culturing, the progenitor cells become immortalized and exhibit commitment to neutrophil, macrophage, and/or dendritic lineage or exhibit multi-lineage blood cell differentiation potential;
- b) administering the cells resulting from step a) to the subject.
6 more elements
Dependencies are inferred from the claim text.